Search engine for other government resources

LiverTox - NCBI Bookshelf

LiverTox provides up-to-date, unbiased and easily accessed information on the diagnosis, cause, frequency, clinical patterns and management of liver ...
www.ncbi.nlm.nih.gov/books/NBK547852/

Safety and efficacy of COVID-19 vaccines in multiple ...

Alemtuzumab is a humanized MAB that targets CD52 receptors on the surface of lymphocytes, causing generalized lymphopenia with a more pronounced ...
www.ncbi.nlm.nih.gov/pmc/articles/PMC8095041/

Warm antibody autoimmune hemolytic anemia

Alemtuzumab: 3 mg intravenously or subcutaneously on day 1 and then if tolerated, 10 mg on day 2, and then if tolerated, 30 mg on day 3, continue with ...
www.ncbi.nlm.nih.gov/pmc/articles/PMC6142448/

Drugs and Lactation Database LactMed - NCBI Bookshelf

The LactMed database contains information on drugs and other chemicals to which breastfeeding mothers may be exposed. It includes information on the ...
www.ncbi.nlm.nih.gov/books/NBK501922/

Long-term Survival in Head and Neck Cancer Impact of Site ...

Objectives/hypothesis: Literature examining long-term survival in head and neck squamous cell carcinoma (HNSCC) with human papillomavirus (HPV) status ...
pubmed.ncbi.nlm.nih.gov/30637762/

Transverse Myelitis Fact Sheet National Institute of ...

Multiple sclerosis and neuromyelitis optica typically require long-term treatment to modify the immune system response. Treatment of MS with ...
www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Transverse-Myelitis-Fact-Sheet

DrugsFDA FDA-Approved Drugs

* Drugs@FDA includes information about drugs, including biological products, approved for human use in the United States (see FAQ), but does not ...
www.accessdata.fda.gov/scripts/cder/daf/

Vaccine Booster FAQ - Queens Health Systems COVID-19 ...

Other biologic agents that are immunosuppressive or immunomodulatory (thymoglobulin, alemtuzumab, rituximab) Medical Conditions with Varied ...
covid.queens.org/vaccine-booster-faq/

Chemotherapy Drug Information Chemocare.com

C225 Cabazitaxel Cablivi Cabozantinib Calcium Leucovorin Calquence Campath Camptosar Camptothecin-11 Capecitabine Caplacizumab-yhdp Capmatinib ...
chemocare.com/chemotherapy/drug-info/default.aspx

Login

{{ $t("message.login.invalid.title") }} {{ $t("message.login.invalid.text") }} {{ $t("message.common.username") }}
online.lexi.com/crlsql/servlet/crlonline

Monoclonal Antibodies - National Cancer Institute

Monoclonal antibodies can cause side effects, which can differ from person to person. The ones you may have and how they make you feel will depend on ...
www.cancer.gov/about-cancer/treatment/types/immunotherapy/monoclonal-antibodies

COVID-19 Vaccine - Penn Medicine

Alemtuzumab (e.g. Lemtrada) Eculizumab (e.g., Soliris) We are scheduling third vaccine dose appointments for severely immunocompromised patients at ...
www.pennmedicine.org/coronavirus/vaccine

Mayo Clinic Laboratories

Medical reference laboratory providing esoteric and genetic testing services, test selection guidance, result interpretation references, and ...
www.mayocliniclabs.com/

National Institute for Occupational Safety Health ...

The Occupational Safety and Health Act of 1970 established NIOSH as a research agency focused on the study of worker safety and health, and empowering ...
www.cdc.gov/niosh/index.htm

Drugs.com Prescription Drug Information Interactions ...

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent ...
www.drugs.com/

PDF HIGHLIGHTS OF PRESCRIBING INFORMATION PD-L1 Combined ...

MSI-H Cancer: 200 mg every 3 weeks for adults and 2 mg/kg (up to 200 mg) every 3 weeks for pediatrics. (2.9) Gastric Cancer: 200 mg every 3 weeks.
www.accessdata.fda.gov/drugsatfda_docs/label/2020/125514s066lbl.pdf

Medications that suppress the immune system Yale Health

Medications that suppress the immune system. Taking high-dose corticosteroids (equal to at least 20 mg of prednisone daily) or any of the other ...
yalehealth.yale.edu/medications-suppress-immune-system

Risk Evaluation and Mitigation Strategies REMS FDA

A Risk Evaluation and Mitigation Strategy (REMS) is a drug safety program that the U.S. Food and Drug Administration (FDA) can require for certain ...
www.fda.gov/drugs/drug-safety-and-availability/risk-evaluation-and-mitigation-strategies-rems

RxList - The Internet Drug Index for prescription drug ...

Medications and prescription drug information for consumers and medical health professionals. Online database of the most popular drugs and their side ...
www.rxlist.com/

Burning Legs Causes Treatments and Symptoms

Causes of burning legs. A burning sensation in your legs may have an obvious explanation, like a leg injury or during or after intense exercise.It ...
www.healthline.com/health/burning-legs